Tag: podcast

Elizabeth McNally, MD, PhD, talks about her recent discoveries in the genetics of cardiovascular and neuromuscular disorders and what we can expect in the next few years in the field of genetic medicine.

For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern’s Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.

Ali Shilatifard, PhD, hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.

Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway. 

Mozziyar Etemadi, MD, PhD, a research assistant professor in Anesthesiology and Biomedical Engineering, is leading deep learning projects in his lab at Northwestern. He talks about a collaboration between Northwestern and Google that uses a deep learning system to predict lung cancer.

Tiny bio-artificial kidneys are growing in the lab of Susan Quaggin, MD. She and a team of scientists, with expertise in stem cells, blood vessels and developmental biology, are accelerating the development of such bioengineered organs.

A new Northwestern Medicine study has delivered some sobering news about heart failure. It found death rates due to heart failure are increasing, especially in people under the age of 65 and specifically among black men.

As we age, almost all of us have some memory loss. This age-related affliction is normal, but a new Northwestern Medicine study suggests it can be improved with non-invasive brain stimulation that sends electromagnetic pulses into a specific area of the brain. Joel Voss, PhD, an associate professor at Northwestern, led this study, published in…

A new approach from the field of ophthalmology shows promise in detecting non-invasive biomarkers of mild cognitive impairment, the precursor to Alzheimer’s disease. Northwestern’s Amani Fawzi, MD, explains.

Results from a randomized phase 3 clinical trial published in The New England Journal of Medicine could change the way women are treated for later stage endometrial cancer. Northwestern’s Daniela Matei, MD, led the trial and shares the details.